We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

News · May 29, 2020

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease

Approval Marks Significant Advance Towards a More Definitive Assessment of Alzheimer’s Based on Brain Imaging

FDA News Release

 

Additional Info

Disclosure statements are available on the authors' profiles:

Further Reading